- Report
- May 2025
- 284 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 191 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 269 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 292 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 271 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 291 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 269 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 282 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 363 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 167 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 164 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 167 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 172 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 114 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 353 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 264 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 208 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 456 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 122 Pages
Global
From €5344EUR$5,850USD£4,557GBP
- Report
- May 2025
- 213 Pages
Global
From €5344EUR$5,850USD£4,557GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more
